{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:34:46Z","timestamp":1778873686038,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"28","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HHSN266200700005C"],"award-info":[{"award-number":["HHSN266200700005C"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HHSN272201400006C"],"award-info":[{"award-number":["HHSN272201400006C"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"American Lebanese Syrian Associated Charities (ALSAC)"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.vaccine.2015.05.011","type":"journal-article","created":{"date-parts":[[2015,5,18]],"date-time":"2015-05-18T13:08:25Z","timestamp":1431954505000},"page":"3186-3192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Egg-adaptive mutations in H3N2v vaccine virus enhance egg-based production without loss of antigenicity or immunogenicity"],"prefix":"10.1016","volume":"33","author":[{"given":"Subrata","family":"Barman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Franks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmine C.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun-Woo","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert G.","family":"Webster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Webby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.05.011_bib0160","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0065-3527(08)00403-X","article-title":"Swine influenza viruses a North American perspective","volume":"72","author":"Vincent","year":"2008","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.vaccine.2015.05.011_bib0165","doi-asserted-by":"crossref","first-page":"8243","DOI":"10.1128\/JVI.74.18.8243-8251.2000","article-title":"Evolution of swine H3N2 influenza viruses in the United States","volume":"74","author":"Webby","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.05.011_bib0170","first-page":"1741","article-title":"Update: Influenza A (H3N2)v transmission and guidelines\u2014five states, 2011","volume":"60","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2015.05.011_bib0175","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3949\/ccjm.79a.12151","article-title":"2012\u20132013 influenza update: hitting a rapidly moving target","volume":"79","author":"Jin","year":"2012","journal-title":"Clevel Clin J Med"},{"key":"10.1016\/j.vaccine.2015.05.011_bib0180","unstructured":"Centers for Disease Control and Prevention. Interim information for clinicians about human infections with H3N2v virus, \u3008http:\/\/www.cdc.gov\/flu\/swineflu\/h3n2v-clinician.htm\u3009; [accessed 19.08.14]."},{"key":"10.1016\/j.vaccine.2015.05.011_bib0185","unstructured":"Centers for Disease Control and Prevention. Variant influenza virus (H3N2v) infection. CDC health alert network (HAN) advisory, \u3008http:\/\/emergency.cdc.gov\/han\/han00351.asp\u3009; [accessed 05.07.14]."},{"key":"10.1016\/j.vaccine.2015.05.011_bib0190","unstructured":"Centers for Disease Control and Prevention. Case count: detected U.S. human infections with H3N2v by state since August 2011, \u3008http:\/\/www.cdc.gov\/flu\/swineflu\/h3n2v-case-count.htm\u3009; [accessed 24.10.14]."},{"key":"10.1016\/j.vaccine.2015.05.011_bib0195","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1093\/cid\/cit649","article-title":"Outbreak of variant influenza A(H3N2) virus in the United States","volume":"57","author":"Jhung","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2015.05.011_bib0200","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/cid\/cit272","article-title":"Human infections with influenza A(H3N2) variant virus in the United States, 2011\u20132012","volume":"57","author":"Epperson","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2015.05.011_bib0205","doi-asserted-by":"crossref","first-page":"e1002791","DOI":"10.1371\/journal.ppat.1002791","article-title":"Pathogenicity and transmissibility of North American triple reassortant swine influenza A viruses in ferrets","volume":"8","author":"Barman","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2015.05.011_bib0210","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1073\/pnas.1119945109","article-title":"Pathogenesis and transmission of swine origin A(H3N2)v influenza viruses in ferrets","volume":"109","author":"Pearce","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2015.05.011_bib0215","unstructured":"Centers for Disease Control and Prevention. Fact sheet: protect yourself against H3N2v, \u3008http:\/\/www.cdc.gov\/flu\/swineflu\/h3n2v-factsheet.htm\u3009 [accessed 19.08.14]."},{"key":"10.1016\/j.vaccine.2015.05.011_bib0220","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1128\/JVI.02625-12","article-title":"Seasonal trivalent inactivated influenza vaccine does not protect against newly emerging variants of influenza A (H3N2v) virus in ferrets","volume":"87","author":"Houser","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.05.011_bib0225","doi-asserted-by":"crossref","first-page":"13480","DOI":"10.1128\/JVI.02434-13","article-title":"Impact of prior seasonal H3N2 influenza vaccination or infection on protection and transmission of emerging variants of influenza A(H3N2)v virus in ferrets","volume":"87","author":"Houser","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.05.011_bib0230","first-page":"237","article-title":"Antibodies cross-reactive to influenza A (H3N2) variant virus and impact of 2010\u201311 seasonal influenza vaccine on cross-reactive antibodies\u2014United States","volume":"61","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2015.05.011_bib0235","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1093\/infdis\/jis500","article-title":"Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v)","volume":"206","author":"Skowronski","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.05.011_bib0240","doi-asserted-by":"crossref","first-page":"6691","DOI":"10.1016\/j.vaccine.2006.05.062","article-title":"Single amino acid substitutions in the hemagglutinin of influenza A\/Singapore\/21\/04 (H3N2) increase virus growth in embryonated chicken eggs","volume":"24","author":"Lu","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.011_bib0245","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1128\/JVI.79.11.6763-6771.2005","article-title":"Improvement of influenza A\/Fujian\/411\/02 (H3N2) virus growth in embryonated chicken eggs by balancing the hemagglutinin and neuraminidase activities, using reverse genetics","volume":"79","author":"Lu","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.05.011_bib0250","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.virol.2006.02.020","article-title":"Molecular changes associated with adaptation of human influenza A virus in embryonated chicken eggs","volume":"350","author":"Widjaja","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2015.05.011_bib0255","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1016\/j.vaccine.2010.03.078","article-title":"The impact of key amino acid substitutions in the hemagglutinin of influenza A (H3N2) viruses on vaccine production and antibody response","volume":"28","author":"Chen","year":"2010","journal-title":"Vaccine"},{"issue":"Pt 1","key":"10.1016\/j.vaccine.2015.05.011_bib0260","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1099\/0022-1317-62-1-153","article-title":"Mapping of antigenic changes in the haemagglutinin of Hong Kong influenza (H3N2) strains using a large panel of monoclonal antibodies","volume":"62","author":"Underwood","year":"1982","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2015.05.011_bib0265","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/srep01822","article-title":"Antigenically intact hemagglutinin in circulating avian and swine influenza viruses and potential for H3N2 pandemic","volume":"3","author":"Tharakaraman","year":"2013","journal-title":"Scientific Rep"},{"key":"10.1016\/j.vaccine.2015.05.011_bib0270","first-page":"93","article-title":"Acid-induced membrane fusion by the hemagglutinin protein and its role in influenza virus biology","volume":"385","author":"Russell","year":"2014","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2015.05.011_bib0275","doi-asserted-by":"crossref","first-page":"6108","DOI":"10.1073\/pnas.100133697","article-title":"A DNA transfection system for generation of influenza A virus from eight plasmids","volume":"97","author":"Hoffmann","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2015.05.011_bib0280","series-title":"U. S. National Institutes of health","author":"Rasband","year":"2014"},{"key":"10.1016\/j.vaccine.2015.05.011_bib0285","unstructured":"World Health Organization. Global influenza surveillance network. Manual for the laboratory diagnosis and virological surveillance of influenza, \u3008http:\/\/wholibdoc.who.int\/publications\/2011\/9789241548090_eng.pdf\u3009; 2011."},{"key":"10.1016\/j.vaccine.2015.05.011_bib0290","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.biochem.69.1.531","article-title":"Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin","volume":"69","author":"Skehel","year":"2000","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.vaccine.2015.05.011_bib0295","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/jac\/dkh155","article-title":"Changes in in vitro susceptibility of influenza A H3N2 viruses to a neuraminidase inhibitor drug during evolution in the human host","volume":"53","author":"Thompson","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.vaccine.2015.05.011_bib0300","doi-asserted-by":"crossref","first-page":"e66325","DOI":"10.1371\/journal.pone.0066325","article-title":"Human H3N2 influenza viruses isolated from 1968 to 2012 show varying preference for receptor substructures with no apparent consequences for disease or spread","volume":"8","author":"Gulati","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2015.05.011_bib0305","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.3390\/v6031294","article-title":"Playing hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection","volume":"6","author":"Tate","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2015.05.011_bib0310","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0092-8674(85)90157-6","article-title":"Fusion mutants of the influenza virus hemagglutinin glycoprotein","volume":"40","author":"Daniels","year":"1985","journal-title":"Cell"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15006325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15006325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,5]],"date-time":"2021-12-05T08:59:57Z","timestamp":1638694797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15006325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":31,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0264410X15006325"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.05.011","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Egg-adaptive mutations in H3N2v vaccine virus enhance egg-based production without loss of antigenicity or immunogenicity","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}